Achilles Therapeutics Statistics

Total Valuation

ACHL has a market cap or net worth of $60.83 million. The enterprise value is -$21.60 million.

Market Cap	60.83M
Enterprise Value	-21.60M

Important Dates

The next estimated earnings date is Wednesday, May 7, 2025, before market open.

Earnings Date	May 7, 2025
Ex-Dividend Date	n/a

Share Statistics

ACHL has 41.10 million shares outstanding. The number of shares has increased by 1.45% in one year.

Current Share Class	n/a
Shares Outstanding	41.10M
Shares Change (YoY)	+1.45%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	6.51%
Owned by Institutions (%)	16.40%
Float	20.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.59
P/TBV Ratio	0.59
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.04, with a Debt / Equity ratio of 0.04.

Current Ratio	6.04
Quick Ratio	5.84
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -52.12% and return on invested capital (ROIC) is -33.60%.

Return on Equity (ROE)	-52.12%
Return on Assets (ROA)	-30.17%
Return on Invested Capital (ROIC)	-33.60%
Return on Capital Employed (ROCE)	-69.03%
Revenue Per Employee	n/a
Profits Per Employee	-$311,065
Employee Count	215
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, ACHL has paid $485,000 in taxes.

Income Tax	485,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +14.73% in the last 52 weeks. The beta is 1.25, so ACHL's price volatility has been higher than the market average.

Beta (5Y)	1.25
52-Week Price Change	+14.73%
50-Day Moving Average	1.31
200-Day Moving Average	1.02
Relative Strength Index (RSI)	75.80
Average Volume (20 Days)	1,642,078

Short Selling Information

Short Interest	797,854
Short Previous Month	57,830
Short % of Shares Out	1.90%
Short % of Float	n/a
Short Ratio (days to cover)	0.23

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-71.93M
Pretax Income	-64.01M
Net Income	-66.88M
EBITDA	-67.23M
EBIT	-71.93M
Earnings Per Share (EPS)	-$1.66

Full Income Statement

Balance Sheet

The company has $86.05 million in cash and $3.62 million in debt, giving a net cash position of $82.43 million or $2.01 per share.

Cash & Cash Equivalents	86.05M
Total Debt	3.62M
Net Cash	82.43M
Net Cash Per Share	$2.01
Equity (Book Value)	103.14M
Book Value Per Share	2.51
Working Capital	93.16M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$63.26 million and capital expenditures -$805,000, giving a free cash flow of -$64.07 million.

Operating Cash Flow	-63.26M
Capital Expenditures	-805,000
Free Cash Flow	-64.07M
FCF Per Share	-$1.56

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ACHL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.45%
Shareholder Yield	n/a
Earnings Yield	-109.94%
FCF Yield	-105.32%

Analyst Forecast

The average price target for ACHL is $4.00, which is 170.27% higher than the current price. The consensus rating is "Buy".

Price Target	$4.00
Price Target Difference	170.27%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-4.35%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1